Abstract
Several studies have reported a possible association between leucocyte telomere length (LTL) and cardio-metabolic diseases (CMDs). However, studies investigating such association are lacking in South Africa despite having a very high prevalence of CMDs. We investigated the association between LTL and CMD risk profile in a black South African population. This was a cross-sectional study with participants > 21 years of age and residing in five townships in Cape Town. CMD markers were compared between men and women and across quartiles of LTL. Linear and logistic regressions relate increasing quartile and Log10LTL with CMD risk profile, with appropriate adjustment. Among 676-participants, diabetes, obesity and hypertension prevalence were 11.5%, 23.1% and 47.5%. Waist-circumference, hip-circumference and highly sensitive c-reactive protein values were significantly higher in women (all p < 0.001), while HDL-C (p = 0.023), creatinine (p = 0.005) and gamma glutamyl transferase (p < 0.001) values were higher in men. In age, sex and BMI adjusted linear regression model, Log10 of LTL was associated with low HDL-C (beta = 0.221; p = 0.041) while logistic regression showed a significant association between Log10LTL and prevalent dyslipidaemia characterised by high LDL-C. In this population, the relationship between LTL and CMD is weak given its association with only HDL-C and LDL-C.
Similar content being viewed by others
Introduction
Telomeres are specialized chromosomal DNA–protein structures that make up the terminal regions of chromosomes and are formed of a highly conserved hexameric (TTAGGG) tandem repeat DNA sequence. Their primary function is to protect and stabilize the genetic material carried by chromosomes in several ways. They shield the chromosomal termini from recognition by the DNA damage response system of the cell, cap chromosome ends thereby preventing them from being degraded or fused together. The length of the telomere is longest at birth and begins to decline within the first 6 weeks of life. In addition to chronological age, there is a wide range of genetic and environmental factors modulating telomere length (TL). Gender1, ethnicity2 and level of physical activity3 have been shown to modulate TL. Moreover, short TL has been shown to be associated with type 2 diabetes in Caucasian, South Asian and Afro-Caribbean4, Insulin Dependent Diabetes Mellitus (IDDM) in white American men5, gestational diabetes mellitus in Chinese population6, coronary artery disease in Chinese men7, vascular dementia in German population8, cardiovascular disease9,10 and hypertension11 in the Adult United State population. This large body of evidence therefore suggests that there is a possible relationship between TL and cardiometabolic diseases (CMDs).
South Africa is facing a quadruple burden of diseases including infectious diseases such as HIV and tuberculosis; maternal and child conditions; non-communicable diseases (NCDs); and violence, injuries and trauma12. CMDs, the leading NCDs, are among the top ten causes of death in South Africa12. Accordingly, identification of biomarkers of CMDs is essential for early diagnosis and appropriate management of these conditions especially in black South Africans marked by higher prevalence of CMDs. Given that CMDs have been shown to be associated with leucocyte telomere length (LTL) in European, American and Asian populations, we therefore undertook this study to investigate the association between LTL and cardio-metabolic profile in a black South African population.
Results
Out of the 1116 participants examined in this study, DNA extracted from stored samples for analysis were available for 676 participants. This number resulted from samples with LTL values which could only be quantified on good quality DNA sample (absorbance 260 nm/280 nm ratio between 1.7 and 2.0). The prevalence of the cardiometabolic disorders was 47.5% for obesity, 23.1% for hypertension and 11.5% for type 2 diabetes (Table 1). Weight, BMI, heart rate, WC, HC and hs-CRP (all p < 0.001) median values were higher in women than men while height (p < 0.001), HDL-C (p = 0.023), creatinine (p = 0.005) and GGT (p < 0.001) values were significantly higher in men than women (Table 1). Moreover, more women than men were obese by all parameters measured [BMI (p < 0.001), WC (p < 0.001), WHR (p = 0.012) and WHtR (p < 0.001)] and had dyslipidaemia [high triglycerides (p = 0.003), high LDL-C values (p = 0.009) and high non-HDL-C values (p = 0.03)].
The distribution of TL was skewed to the right (skewness = 3.45), indicating that TL values were not normally distributed (Fig. 1A). In order to have a normal distribution of TL, it was Log10 transformed (Fig. 1B).
Correlation analysis showed a significant positive association between LTL and HDL-C (r = 0.082, p = 0.034) (Fig. 2A). In women, LTL was negatively correlated with LDL-C (r = − 0.1, p = 0.037) (Fig. 2B) and non-HDL-C (r = − 0.101, p = 0.034) (Fig. 2C). In men, there was a significant positive correlation between LTL and Urea (r = 0.179, p = 0.007) (Fig. 2D).
The association between LTL and cardiometabolic profile was investigated by categorizing the LTL values into quartiles with the first being the lowest and the fourth being the highest (Table 2). Amongst the different cardio-metabolic parameters investigated, quartiles of LTL were shown to be positively and significantly associated with HDL-C (Table 3).
Linear regression carried out in age and sex adjusted model showed a significant association between Log10 LTL and HDL-C (beta = 0.028; p = 0.041) (Table 4) while increasing quartiles of LTL was not associated with HDL-C in linear regression models with similar levels of adjustment. Neither increasing quartiles of LTL nor Log10 LTL was associated with other cardio-metabolic parameters in age and sex adjusted linear regression models. In logistic regressions, there were no associations between quartiles of LTL and diabetes, hypertension, any dyslipidaemia and obesity variables. However, when LTL was Log transformed, there was a significant association between Log10 LTL and prevalent dyslipidaemia with High LDL-C > 3.0 mmol/L (OR = 0.41, p = 0.045) (Table 5).
Discussion
This study examined the associations of LTL with cardiometabolic variables of adiposity, hypertension, type 2 diabetes and dyslipidaemia in a black urban South African population. Linear regression carried out in age and sex adjusted model showed a significant association between Log10LTL and HDL-C as continuous variable. In logistic regression model, Log10LTL was associated with prevalent dyslipidaemia characterized by high LDL-C. Correlation analysis showed that LTL was associated with Total Cholesterol and non-HDL-C in women and urea in men. However, neither quartiles of LTL nor Log transformed values were associated with hypertension, obesity and type 2 diabetes, which was surprising and warrants further exploration in this population.
The association between LTL and some lipid parameters in the study suggests a possible but weak relationship between shortened TL and dyslipidaemia. Similar results were obtained in the United States13 and in Iran14. Dyslipidaemia, characterised by altered serum lipid levels is associated with several disease conditions including coronary heart disease, hypertension, diabetes, obesity and oxidative stress which is related with LTL shortening. Although most published literature reported a positive association between short telomere length and a high prevalence of diabetes, obesity, hypertension and other cardiovascular diseases, in this study there were no associations between LTL with diabetes, hypertension or obesity. A meta-analysis of multiple studies found a significant negative association between LTL and diabetes15 while a systematic review reported a weak to moderate association between obesity and telomere length16. Short TL was also positively correlated with high SBP and DBP11, high fasting glycaemia17, altered lipid profile markers6 and cardiovascular diseases10,18,19,20. The proposed pathway of the association between shortened TL and CMDs reported is bi-directional with cardio-metabolic diseases causing shortening of telomere length and short telomere length increasing the risk of cardio-metabolic diseases. However, these studies have all been carried out in European, Asian and American population, with no studies from Africa, suggesting that the lack of association in our study could be as a result of population differences. Moreover, the sample size of these cross-sectional studies and systematic reviews/meta-analysis was large enough (minimum > 5000) compared to 676 in our study. Therefore, their studies had more power to detect differences compared to our study.
It is possible that LTL could also be determined by the origin and evolution of individuals. Hansen reported shorter TL in Europeans and African Americans originating from Western Africa compared to those living in Africa originating from Tanzania (Eastern Africa)21. These results are consistent with other studies reporting longer telomere length in Black Africans compared to white Europeans and Americans in both children and adult22,23,24,25,26,27. However, TL was observed to be longer in white compared to black teachers in South Africa28. In this South African population, the risk of cardiovascular disease was higher in black teachers that white teachers28. These results shows that genetic differences between ethnic groups and environmental factors ‘contribute’ to overall telomere length.
Unlike this study findings showing no association between TL and age, several studies have reported a significant negative correlation between TL and chronological age. TL shortens with age and age associated disorders. A systematic review showed an average decrease of 21.91 base pair TL/year across cross-sectional studies and 32.2–45.5 base pair TL/year in 5 longitudinal studies29. Another important factor that affects TL is sex with several studies showing TL to be longer in women than men9,30,31,32,33. However, in the present study there was no association between LTL and gender. Even though the present study was carried out in an African population which is different from studies reporting an association between TL and age/gender (Asia, Europe and USA) and could probably explain the difference in the results, further research is needed to explore these associations in Africans. Moreover, the black South African population in which the study was carried out is genetically diverse with some having gene flow from Europe, East Africa and South Asia34. This genetic diversity in the study population could be responsible for the difference in the results obtained.
The cross-sectional design of the study prevents conclusions on a causal relationship between LTL and the CMD risk factors investigated. The small sample size of the study and the low sample realisation in men (34%) characteristic of epidemiological studies in this country and probably due to their reluctance to participate, particularly for the drawing of blood samples is another limitation. In this study, multiple hypothesis testing (MHT) was not performed. As such, the results would not withstand a stringent MHT based correction which constitute a possible limitation.
In a black urban South African population, LTL was weakly associated with HDL-C and LDL-C, but not with diabetes, hypertension or obesity. Although the association of LTL with cardiometabolic risk factors have been reported in many populations, there is a paucity of data in African populations. Further research, particularly in longitudinal studies, is required to clearly elucidate the relationship between LTL and CMDs in Africans.
Materials and methods
Study site and population
Participants consisted of > 21 years old black men and women residing in Cape Town. This cross-sectional study titled Cardiovascular Risk in Black South Africans (CRIBSA) was conducted in 2008–2009 with data collected by a 3-stage cluster sampling as previously described35. This sampling technique was used with quotas, which were pre-specified by age and sex categories to ensure a representative sample, Recruitment took place during office hours and those excluded were the following: pregnant and lactating women, individuals who were bedridden, unable to give consent, on tuberculosis treatment, on antiretroviral therapy, cancer patients having received treatment within the last year and individuals residing in Cape Town for less than three months.
Ethics approval was obtained from the South African Medical Research Council’s Human Research Ethics Committee (EC026-9/2016) and the University of Cape Town’s Research and Ethics Committee (224/2006), and informed consent was obtained from all participants. The research was performed in accordance with the declaration of Helsinki and all methods carried out with relevant guidelines and regulations.
Data collection
Data, which were collected by trained fieldworkers, included administered questionnaires, clinical examinations and biochemical analyses. Clinical examinations comprised anthropometry (height, weight, and waist and hip circumferences) and blood pressure (BP) measured using standard techniques36. A calibrated scale was used to measure weight to the nearest 0.5 kg with each participant barefoot and in light clothing. A stadiometer was used to measure height to the nearest 0.1 cm. A flexible tape measured waist and hip circumferences to the nearest 0.1 cm. For waist circumference (WC), the tape was placed approximately 2 cm above the umbilicus while hip circumference (HC) was measured at the maximum posterior protuberance of the buttocks with the participant standing upright with feet together. Three BP measurements were taken at intervals of 2 min, using an Omron BP monitor after the participant had been rested for at-least 5 min. The average of the second and third BP measurements was used for analysis.
After an overnight fast of approximately 10 h, blood samples were collected by venepuncture into EDTA and dry tubes and a portion processed for biochemical analysis. Plasma glucose (hexokinase) was measured using a colorimetric method according to the manufacturer’s protocol. Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and triglycerides were measured in serum using standard enzymatic techniques37,38,39. Low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald formula40, while non-HDL-C was calculated using the formula: TC–HDL-C. An oral glucose tolerance test (OGTT) was administered with blood samples collected 2 h after a glucose load41. All colorimetric measurements were conducted using a Beckman Coulter AU 500 spectrophotometer. Serum creatinine (CAYMAN CHEMICAL), gamma glutamyl transferase (Abcam) and highly sensitive c-reactive protein (hs-CRP) (BIOMATIK ELISA) measurements were conducted on stored serum samples according to the manufacturer’s protocol. TL assay was conducted from DNA samples extracted from whole blood stored at −80 °C in EDTA tubes using the salt extraction technique. Briefly, 5 mL blood samples in EDTA tubes were defrosted to room temperature and poured into a 50 mL centrifuge tube. Thirty mL lysis buffer (see supplementary material) was added, and red blood cells were lysed by incubation on ice and vortexing. After lysis of red blood cells, the pellets were washed thrice with phosphate buffered saline (see supplementary material) which was later discarded. The pellets were then incubated with nuclear lysis buffer (see supplementary material) overnight at 60 °C. The next day, the supernatant was collected, and the proteins precipitated using 1 mL saturated sodium chloride (6 M) solution. The supernatant containing the DNA was collected into new 15 mL centrifuge tubes and absolute ethanol added to precipitate the DNA by inversion. Precipitated DNA was removed and washed with 70% ethanol. After washing, the precipitate was dissolved in Tris Ethylene Diamine Tetra-Acetate buffer (see supplementary material) and the concentration and quality of the DNA measured using a Nano drop. All samples with absorbance 260 nm/280 nm ratio from 1.7 to 2 were diluted to 5 mg/mL using polymerase chain reaction (PCR) grade water and TL measured by quantitative real time PCR using the method described by O’Callaghan and Fenech42.
Serial dilutions of the telomere standard and the single copy gene (36B4) standard were made as described by O’Callaghan and Fenech42. A master mix solution containing Power SYBR I (AmpliTaq Gold DNA polymerase, dNTPs, SYBR I Green Dye, optimised buffers and passive reference dye (ROX) (10μL, 1×)), forward primer (1μL, 0.1 μM), reverse primer (1μL, 0.1 μM) and ddH2O (4uL) was prepared, mixed well and briefly centrifuged. Using a multichannel pipetted, 16 μL master mix solution were pipetted into each well of a 96 well plate. Into the corresponding wells were added 4 μL each of DNA sample, standards, positive and non-template control (distilled water) in duplicates. The plate was sealed with an optical clear film, centrifuged briefly and run in a QuantStudio 7 Flex Real Time PCR Thermocycler using the following PCR conditions; 10 min at 95 °C, followed by 40 cycles of 95 °C for 15 s 60 °C for 1 min, followed by a dissociation (or melt) curve. At the end of the run, the plate was removed and discarded. Each sample was amplified twice, using telomere forward and reverse primers and the single copy gene forward and reverse primers. After amplification was completed the AB software produced a value for each reaction that is equivalent to kb/reaction based on the telomere standard curve values. The kb/reaction for telomere and genome copies/reaction for diploid genome copy values were exported and used to calculate the LTL in kilobase (kb) as follows; LTL = \(\frac{{{\text{telomere}}\;{\text{kilobase}}\;{\text{per}}\;{\text{reaction}}\;{\text{value}}}}{{{\text{diploid}}\;{\text{genome}}\;{\text{copy}}\;{\text{number}}}}\).
Definitions
Body mass index (BMI), calculated as weight (kg)/height (m) squared, classified participants into three categories of generalised adiposity: normal weight (18 ≤ BMI < 25 kg/m2), overweight (25 ≤ BMI < 30 kg/m2) and obese (BMI ≥ 30 kg/m2)43. Central obesity was determined using the following criteria: WC > 94 cm in men and > 80 cm in women, waist-to-hip ratio (WHR) ≥ 0.9 in men and ≥ 0.85 in women44 or waist-to-height ratio (WHtR) > 0.545. Hypertension was defined as systolic BP (SBP) ≥ 140 mmHg or diastolic BP (DBP) ≥ 90 mmHg or known hypertension on treatment46. Dyslipidaemia was defined as TC > 5 mmol/l, triglycerides > 1.5 mmol/L, HDL-C < 1.2 mmol/L, LDL-C > 3.0 mmol/L and non-HDL-C > 3.37 mmol/L or taking anti-lipid agents47. Diabetes was defined as fasting plasma glucose ≥ 7.0 mmol/L and/ or 2-h post glucose load ≥ 11.1 mmol/L, previously diagnosed or taking antidiabetic medications41.
Statistical analysis
Data analysis was carried out using SPSS Version 21 software. Continuous variables are presented as medians (25th to 75th percentiles) and categorical variables as counts (percentages). Mann Whitney U test was used to compare baseline characteristics by sex. TL was categorised into quartiles and the linear trend in CMD profile (continuous variables) across the different quartiles of TL was computed using the median test. Similarly, chi square test was computed and the linear-by-linear association used to compare the trend in proportions of disease conditions (categorical variable) across the quartiles of TL. Spearman correlation was used to assess the association between quartile of TL and cardio-metabolic parameters. The interactions between TL categories and cardio-metabolic risk profile were tested using linear and logistic regressions, by incorporating in the same model the main effects of the variables of interest as well as their interaction term with TL. In linear and logistic regression analyses, TL was log transformed. A p value < 0.05 was considered statistically significant.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Willeit, P. et al. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler. Thromb. Vasc. Biol. 30, 1649–1656 (2010).
Diez Roux, A. V. et al. Race/ethnicity and telomere length in the multi-ethnic study of atherosclerosis. Aging Cell 8, 251–257 (2009).
Puterman, E. et al. The power of exercise: Buffering the effect of chronic stress on telomere length. PLoS ONE 5, e10837 (2010).
Salpea, K. D. et al. Association of telomere length with type 2 diabetes, oxidative stress and ucp2 gene variation. Atherosclerosis 209, 42–50 (2010).
Jeanclos, E. et al. Shortened telomere length in white blood cells of patients with iddm. Diabetes 47, 482–486 (1998).
Weng, Q. et al. Leukocyte telomere length, lipid parameters and gestational diabetes risk: A case-control study in a Chinese population. Sci. Rep. 9, 8483. https://doi.org/10.1038/s41598-019-44968-9 (2019).
Wang, Y. Y. et al. Association of shorter mean telomere length with large artery stiffness in patients with coronary heart disease. Aging Male 14, 27–32 (2011).
Von Zglinicki, T. et al. short telomeres in patients with vascular dementia: An indicator of low antioxidative capacity and a possible risk factor?. Lab. Investig. 80, 1739–1747 (2000).
Fitzpatrick, A. L. et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am. J. Epidemiol. 165, 14–21 (2007).
Xu, C. et al. Association between leucocyte telomere length and cardiovascular disease in a large general population in the united states. Sci. Rep. https://doi.org/10.1038/s41598-019-57050-1 (2020).
Huang, Y.-Q. et al. The relationship between mean telomere length and blood pressure: Results from the National Health and Nutrition Examination Surveys. Ann. Transl. Med. 8(8), 535. https://doi.org/10.21037/atm.2020.03.205 (2020).
STATISTICS SOUTH AFRICA. STATISTICAL RELEASE P0309.3 Mortality and causes of death in South Africa: Findings from death notification (2017).
Chen, Y. F., Zhou, K. W., Yang, G. Z. & Chen, C. Association between lipoproteins and telomere length in us adults: Data from the NHANES 1999–2002. Lipids Health Dis. https://doi.org/10.1186/s12944-019-1030-7 (2019).
Karimi, B., Yunesian, M., Nabizadeh, R. & Mehdipour, P. Serum level of total lipids and telomere length in the male population: A cross-sectional study. Am. J. Mens Health https://doi.org/10.1177/1557988319842973 (2019).
Wang, J. et al. Association between telomere length and diabetes mellitus: A meta-analysis. J. Int. Med. Res. 44, 1156–1173 (2016).
Mundstock, E. et al. Effect of obesity on telomere length: Systematic review and meta-analysis. Obesity 23, 2165–2174 (2015).
Grunnet, L. G. et al. Leukocyte telomere length is associated with elevated plasma glucose and HbA1c in young healthy men independent of birth weight. Sci. Rep. 9, 7639. https://doi.org/10.1038/s41598-019-43387-0 (2019).
Raschenberger, J. et al. association of relative telomere length with cardiovascular disease in a large chronic kidney disease cohort: The GCKD study. Atherosclerosis 242, 529–534 (2015).
Brouilette, S. W. et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: A nested case-control study. Lancet 369, 107–114 (2007).
Ding, H. et al. Telomere length and risk of stroke in Chinese. Stroke 43, 658–663 (2012).
Hansen, M. E. B. et al. Shorter telomere length in Europeans than in Africans due to polygenetic adaptation. Hum. Mol. Genet. 25, 2324–2330 (2016).
Hunt, S. C. et al. Leukocyte telomeres are longer in African Americans than in whites: The National Heart, Lung, and Blood Institute Family Heart Study and the Bogalusa Heart Study. Aging Cell 7, 451–458 (2008).
Zhu, H. et al. Leukocyte telomere length in healthy Caucasian and African-American adolescents: Relationships with race, sex, adiposity, adipokines, and physical activity. J. Pediatr. 158, 215–220 (2011).
Adler, N. et al. Educational attainment and late life telomere length in the Health, Aging and Body Composition Study. Brain Behav. Immun. 27, 15–21 (2013).
Needham, B. L. et al. Socioeconomic status, health behavior, and leukocyte telomere length in the National Health and Nutrition Examination Survey, 1999–2002. Soc. Sci. Med. 85, 1–8 (2013).
Factor-Litvak, P. et al. Leukocyte telomere length in newborns: Implications for the role of telomeres in human disease. Pediatrics 137, e20153927 (2016).
Needham, B. L., Hicken, M. T., Govia, I. O., Mitchell, C. & Abdou, C. M. Maternal social disadvantage and newborn telomere length in archived dried blood spots from the Michigan neonatal biobank. Biodemogr. Soc. Biol. 63, 221–235 (2017).
Kanel, R. V., Malan, N. T., Hamer, M. & Malan, L. Comparison of telomere length in black and white teachers from South Africa: The sympathetic activity and ambulatory blood pressure in Africans study. Psychosom. Med. 77, 26–32 (2015).
Müezzinler, A., Zaineddin, A. K. & Brenner, H. A systematic review of leukocyte telomere length and age in adults. Ageing Res. Rev. 12, 509–519 (2013).
Bekaert, S. et al. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell 6, 639–647 (2007).
Benetos, A. et al. Telomere length as an indicator of biological aging—The gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 37, 381–385 (2001).
Gardner, M. et al. Gender and telomere length: Systematic review and meta-analysis. Exp. Gerontol. 51, 15–27 (2014).
Nawrot, T. S., Staessen, J. A., Gardner, J. P. & Aviv, A. Telomere length and possible link to x chromosome. The Lancet 363, 507–510 (2004).
Sengupta, D. et al. Genetic substructure and complex demographic history of South African Bantu speakers. Nat. Commun. 12, 2080. https://doi.org/10.1038/s41467-021-22207 (2021).
Peer, N. et al. Rising diabetes prevalence among urban-dwelling Black South Africans. PLoS ONE 7(9), e43336 (2012).
Alberti, K. G., Zimmet, P. & Shaw, J. Metabolic syndrome—A new world-wide definition. A consensus statement from the international diabetes federation. Diabet. Med. 23, 469–480 (2006).
Allain, C. C., Poon, L. S., Chan, C. S., Richmond, W. & Fu, P. C. Enzymatic determination of total serum cholesterol. Clin. Chem. 20, 470–475 (1974).
Jabbar, J., Siddique, I. & Qaiser, R. Comparison of two methods (precipitation manual and fully automated enzymatic) for the analysis of HDL and LDL cholesterol. J. Pak. Med. Assoc. 56, 59–61 (2006).
Mcgowan, M. W., Artiss, J. D., Strandbergh, D. R. & Zak, B. A. Peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 29, 538–542 (1983).
Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972).
WHO. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Geneva: World Health Org. (1999).
O’Callaghan, N. J. & Fenech, M. A quantitative PCR method for measuring absolute telomere length. Biol. Proc. Online 13, 3. https://doi.org/10.1186/1480-9222-13-3 (2011).
WHO. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. Geneva: World Health Organization. (2000).
WHO. Waist Circumference and Waist–Hip Ratio: Report of a WHO Expert Consultation. Geneva, 8–11 December 2008. Geneva: World Health Organization. (2011).
Ashwell, M. & Hsieh, S. D. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int. J. Food. Sci. Nutr. 56, 303–307 (2005).
Williams, B. et al. ESC scientific document group. esc/esh guidelines for the management of arterial hypertension. Eur. Heart J. 39, 3021–3104 (2018).
Diagnosis, management and prevention of the common dyslipidaemias in South Africa-clinical guideline. South African Medical Association and Lipid and Atherosclerosis Society of Southern Africa Working Group. S. Afr. Med. J. 90, 164–174, 176–178 (2000).
Acknowledgements
The authors would like to acknowledge the participants, fieldworkers, SAMRC research nurse fieldworkers Debbie Jonathan and Theresa Gogela, fieldwork coordinator Erica April, study manager Serena van Haght, and statisticians Nomonde Gwebushe, Rebecca Shanmugam and Ria Laubscher.
Funding
This work was supported by the South African Medical Research Council (SAMRC): SAMRC-RFA-IRF-02-2016; an unrestricted grant from Servier Laboratories (South Africa); the Initiative for Cardiovascular Health Research in Developing Countries (IC Health) Foundation Council; and Brigham and Women’s Hospital, Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
The authors confirm contribution to the paper as follows: conception and design; N.P. and A.P.K. conceived and designed the study, E.N.N. carried out the research work, prepared the draft manuscript, analysis and interpretation of results, T.M. and A.P.K. supervised the research work, T.M., C.L., N.L. reviewed the results and all authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ngwa, N.E., Matsha, T.E., Lombard, C. et al. Cardiometabolic profile and leukocyte telomere length in a Black South African population. Sci Rep 12, 3323 (2022). https://doi.org/10.1038/s41598-022-07328-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-07328-8
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.